The clinical course of Lyme disease is well known to be non-linear: a significant proportion of patients report fluctuating symptoms, which are often difficult to link unequivocally to the activity of the infection. The pathogen’s generational cycle may manifest itself in symptom flare-ups occurring every 2–4 weeks. This cyclical pattern may also be influenced by co-infections occurring alongside members of the Borrelia burgdorferi sensu lato subgenus. However, everyday experience shows that certain external factors – particularly the weather, the changing seasons, temperature fluctuations or even changes in air pressure – can also exacerbate symptoms. Although these observations were long considered largely anecdotal, in recent years an increasing body of scientific evidence suggests that complex neuroimmunological and physiological mechanisms underlie this phenomenon.
Infection with Borrelia burgdorferi, the bacterium that causes Lyme disease, not only induces local inflammation but also triggers a systemic immune response. This response – particularly in chronic or post-infectious conditions – can result in increased sensitivity to external stimuli affecting the body’s homeostasis. Changes in temperature, for example, influence peripheral circulation, nervous system conduction and the production of inflammatory mediators. Cold causes vasoconstriction, which can impair oxygenation of tissues that are already compromised, whilst in warm conditions vasodilation and hypotension may predominate, which can exacerbate fatigue, dizziness or cognitive complaints.
Seasonal changes have a particularly complex effect. During the autumn-winter period, exposure to sunlight decreases, which can lead to lower vitamin D levels. The immunomodulatory role of vitamin D is well known: its deficiency can exacerbate inflammatory responses and impair the regulation of the immune system. In addition, changes in the circadian rhythm and melatonin production also affect sleep quality, which has a direct impact on pain perception and cognitive function. In patients with Lyme disease, where the nervous system is often affected, these changes can cause a particularly marked exacerbation of symptoms.
Changes in air pressure and humidity may also play a role. Although the exact mechanism is not fully understood, it is thought that microscopic pressure changes occurring in the joint capsules and connective tissues may contribute to an increase in pain perception. A similar phenomenon has been observed in other chronic pain syndromes, such as rheumatoid arthritis or fibromyalgia, whose pathophysiology partly overlaps with the conditions seen in Lyme disease; indeed, Lyme disease may even play a role in the development of these conditions of unknown aetiology.
It is also important to highlight the role of stress and the autonomic nervous system. Vegetative reactions often associated with weather fronts – such as fluctuations in heart rate, changes in blood pressure, and headaches – may be more pronounced in patients with Lyme disease. This may be due to autonomic dysfunction, which has been described in several studies of Lyme disease with chronic symptoms. An imbalance in the sympathetic-parasympathetic system may exacerbate inflammatory processes and pain sensitivity.
In light of the above factors, it becomes clear why patients experience a worsening of symptoms under certain environmental conditions. However, the question is not merely one of identifying the causes, but also of determining what strategies can help alleviate the symptoms.
One key to preparation is awareness. If the patient recognises the patterns that exist between their symptoms and external conditions, they have the opportunity to take preventive measures. For example, during cold weather, it is particularly important to ensure appropriate clothing and maintain peripheral circulation, whilst in warm weather, ensuring adequate fluid intake and electrolyte balance becomes a priority.
Optimising vitamin D levels can be particularly important during the autumn and winter months. In Lyme disease, rather than the usual daily dose, the maximum dose recommended for infections (4,000 IU/day) may be considered; indeed, in cases of deficiency, this can be temporarily increased to as much as 50,000 IU/week, under medical supervision. Numerous studies confirm that adequate vitamin D status not only regulates the immune response but can also bring about improvement in chronic pain syndromes. Furthermore, improving sleep quality – for example, by adhering to sleep hygiene rules or using melatonin if necessary – can also contribute to stabilising symptoms.
Supporting the balance of the autonomic nervous system is also possible through targeted techniques. These include, for example, breathing exercises, moderate-intensity physical activity, or even mindfulness-based stress reduction. These methods have been shown to reduce inflammatory markers and improve patients’ quality of life.
The role of pharmacological and complementary therapies must not be overlooked either. In certain cases, the use of anti-inflammatory drugs, neuropathic pain relievers or antioxidants may be warranted, particularly if symptoms worsen significantly in response to external factors. However, each such intervention requires individual assessment.
Overall, it can be said that the fluctuation of Lyme disease symptoms is not merely a consequence of the dynamics of the infection, but the result of a complex interaction between the body and the environment. Recognising and consciously managing external factors provides an opportunity for patients to take an active role in stabilising their condition. Although the scientific evidence is not yet complete in every detail, both current data and clinical experience support the view that taking environmental factors into account is an important part of the complex management of Lyme disease.
Sources:
https://pubmed.ncbi.nlm.nih.gov/25999221/
https://www.nature.com/articles/nrdp201690
https://www.sciencedirect.com/science/article/abs/pii/S0891552007001274
https://www.tandfonline.com/doi/full/10.1586/14787210.2014.940900
https://lymenet.hu/2025/11/21/felejtsuk-el-a-lyme-foltot-ezek-a-lyme-kor-elso-tunetei/
(C) Lyme Borreliosis Foundation
